NET PROFIT (x1000 SEK)
EMPLOYEES
Scanpharm A/S
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
-6,588
|
-9,138
|
-14,832 |
Total assets |
47,050
|
44,384
|
39,760 |
Current assets |
26,144
|
24,132
|
20,071 |
Current liabilities |
39,418
|
37,789
|
32,271 |
Equity capital |
2,233
|
2,245
|
2,063 |
- share capital |
4,466
|
4,489
|
4,126 |
Employees (average) |
75
![]() |
75
![]() |
75 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
4.7%
|
5.1%
|
5.2% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) | |||
Current ratio |
66.3%
|
63.9%
|
62.2% |
Return on equity (ROE) |
-295.0%
|
-407.0%
|
-719.0% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.